nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C19—coronary artery disease	0.201	1	CbGaD
Tolterodine—CYP2C9—Fenofibrate—coronary artery disease	0.0248	0.0506	CbGbCtD
Tolterodine—CYP2C19—Gemfibrozil—coronary artery disease	0.0239	0.0487	CbGbCtD
Tolterodine—CYP2C19—Clopidogrel—coronary artery disease	0.0207	0.0422	CbGbCtD
Tolterodine—CYP2C9—Gemfibrozil—coronary artery disease	0.0198	0.0405	CbGbCtD
Tolterodine—CYP2C19—Telmisartan—coronary artery disease	0.0181	0.0369	CbGbCtD
Tolterodine—KCNH2—purkinje fiber—coronary artery disease	0.018	0.427	CbGeAlD
Tolterodine—CYP2C9—Clopidogrel—coronary artery disease	0.0172	0.0351	CbGbCtD
Tolterodine—CYP3A4—Ticagrelor—coronary artery disease	0.0162	0.033	CbGbCtD
Tolterodine—CYP2C9—Pitavastatin—coronary artery disease	0.015	0.0307	CbGbCtD
Tolterodine—CYP2C9—Valsartan—coronary artery disease	0.0146	0.0298	CbGbCtD
Tolterodine—CYP2C19—Timolol—coronary artery disease	0.0146	0.0297	CbGbCtD
Tolterodine—CYP3A4—Fenofibrate—coronary artery disease	0.0144	0.0294	CbGbCtD
Tolterodine—CYP2C19—Rosuvastatin—coronary artery disease	0.0133	0.0272	CbGbCtD
Tolterodine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.013	0.0265	CbGbCtD
Tolterodine—CYP2C19—Simvastatin—coronary artery disease	0.0124	0.0253	CbGbCtD
Tolterodine—CYP2C19—Lovastatin—coronary artery disease	0.0121	0.0247	CbGbCtD
Tolterodine—CYP2D6—Niacin—coronary artery disease	0.0119	0.0243	CbGbCtD
Tolterodine—CYP3A4—Gemfibrozil—coronary artery disease	0.0115	0.0235	CbGbCtD
Tolterodine—CYP2C9—Rosuvastatin—coronary artery disease	0.0111	0.0226	CbGbCtD
Tolterodine—CYP2D6—Timolol—coronary artery disease	0.0111	0.0226	CbGbCtD
Tolterodine—CYP2C19—Atorvastatin—coronary artery disease	0.011	0.0225	CbGbCtD
Tolterodine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0108	0.022	CbGbCtD
Tolterodine—CYP2C9—Simvastatin—coronary artery disease	0.0103	0.021	CbGbCtD
Tolterodine—CYP2C19—Losartan—coronary artery disease	0.0101	0.0206	CbGbCtD
Tolterodine—CYP2C9—Pravastatin—coronary artery disease	0.0101	0.0206	CbGbCtD
Tolterodine—CYP2C9—Lovastatin—coronary artery disease	0.0101	0.0206	CbGbCtD
Tolterodine—CYP3A4—Clopidogrel—coronary artery disease	0.01	0.0204	CbGbCtD
Tolterodine—CYP2D6—Captopril—coronary artery disease	0.00976	0.0199	CbGbCtD
Tolterodine—CYP2D6—Simvastatin—coronary artery disease	0.00943	0.0192	CbGbCtD
Tolterodine—CYP3A4—Eplerenone—coronary artery disease	0.0093	0.019	CbGbCtD
Tolterodine—KCNH2—endocardium—coronary artery disease	0.00926	0.22	CbGeAlD
Tolterodine—CYP2D6—Lovastatin—coronary artery disease	0.00922	0.0188	CbGbCtD
Tolterodine—CYP2D6—Pravastatin—coronary artery disease	0.00922	0.0188	CbGbCtD
Tolterodine—CYP2C9—Atorvastatin—coronary artery disease	0.00919	0.0187	CbGbCtD
Tolterodine—CYP2C9—Losartan—coronary artery disease	0.0084	0.0171	CbGbCtD
Tolterodine—CYP2D6—Atorvastatin—coronary artery disease	0.0084	0.0171	CbGbCtD
Tolterodine—CYP3A4—Enalapril—coronary artery disease	0.00829	0.0169	CbGbCtD
Tolterodine—CYP2C9—cardial valve—coronary artery disease	0.00752	0.179	CbGeAlD
Tolterodine—CYP3A4—Rosuvastatin—coronary artery disease	0.00645	0.0131	CbGbCtD
Tolterodine—CYP3A4—Ezetimibe—coronary artery disease	0.00645	0.0131	CbGbCtD
Tolterodine—CYP3A4—Simvastatin—coronary artery disease	0.00599	0.0122	CbGbCtD
Tolterodine—CYP3A4—Pravastatin—coronary artery disease	0.00586	0.012	CbGbCtD
Tolterodine—CYP3A4—Lovastatin—coronary artery disease	0.00586	0.012	CbGbCtD
Tolterodine—CYP3A4—Atorvastatin—coronary artery disease	0.00534	0.0109	CbGbCtD
Tolterodine—CYP3A4—Losartan—coronary artery disease	0.00489	0.00996	CbGbCtD
Tolterodine—Phenprocoumon—VKORC1—coronary artery disease	0.00142	0.574	CrCbGaD
Tolterodine—KCNH2—cardiac ventricle—coronary artery disease	0.000779	0.0185	CbGeAlD
Tolterodine—KCNH2—myocardium—coronary artery disease	0.000733	0.0174	CbGeAlD
Tolterodine—CHRM2—heart—coronary artery disease	0.000708	0.0168	CbGeAlD
Tolterodine—CHRM2—cardiovascular system—coronary artery disease	0.000668	0.0159	CbGeAlD
Tolterodine—CHRM1—cardiovascular system—coronary artery disease	0.000608	0.0145	CbGeAlD
Tolterodine—KCNH2—heart—coronary artery disease	0.000512	0.0122	CbGeAlD
Tolterodine—KCNH2—cardiovascular system—coronary artery disease	0.000483	0.0115	CbGeAlD
Tolterodine—KCNH2—cardiac atrium—coronary artery disease	0.000438	0.0104	CbGeAlD
Tolterodine—CYP2C9—heart—coronary artery disease	0.000416	0.00989	CbGeAlD
Tolterodine—CYP2C19—blood—coronary artery disease	0.0004	0.00952	CbGeAlD
Tolterodine—CYP2C9—cardiovascular system—coronary artery disease	0.000392	0.00933	CbGeAlD
Tolterodine—KCNH2—blood—coronary artery disease	0.000382	0.00908	CbGeAlD
Tolterodine—CYP2C9—blood—coronary artery disease	0.00031	0.00738	CbGeAlD
Tolterodine—Labetalol—ADRB1—coronary artery disease	0.00031	0.125	CrCbGaD
Tolterodine—Labetalol—ADRB2—coronary artery disease	0.00026	0.105	CrCbGaD
Tolterodine—CYP3A4—blood—coronary artery disease	0.000237	0.00563	CbGeAlD
Tolterodine—CYP2D6—blood—coronary artery disease	0.000233	0.00554	CbGeAlD
Tolterodine—Fatigue—Olmesartan—coronary artery disease	0.000173	0.00105	CcSEcCtD
Tolterodine—Dyspepsia—Niacin—coronary artery disease	0.000173	0.00104	CcSEcCtD
Tolterodine—Dry mouth—Furosemide—coronary artery disease	0.000173	0.00104	CcSEcCtD
Tolterodine—Constipation—Valsartan—coronary artery disease	0.000173	0.00104	CcSEcCtD
Tolterodine—Hypersensitivity—Fenofibrate—coronary artery disease	0.000172	0.00104	CcSEcCtD
Tolterodine—Pain—Olmesartan—coronary artery disease	0.000172	0.00104	CcSEcCtD
Tolterodine—Constipation—Olmesartan—coronary artery disease	0.000172	0.00104	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Trandolapril—coronary artery disease	0.000171	0.00103	CcSEcCtD
Tolterodine—Confusional state—Furosemide—coronary artery disease	0.000171	0.00103	CcSEcCtD
Tolterodine—Arthralgia—Losartan—coronary artery disease	0.00017	0.00103	CcSEcCtD
Tolterodine—Chest pain—Losartan—coronary artery disease	0.00017	0.00103	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Enalapril—coronary artery disease	0.00017	0.00103	CcSEcCtD
Tolterodine—Dyspepsia—Pravastatin—coronary artery disease	0.00017	0.00103	CcSEcCtD
Tolterodine—Tachycardia—Perindopril—coronary artery disease	0.00017	0.00103	CcSEcCtD
Tolterodine—Anxiety—Losartan—coronary artery disease	0.00017	0.00103	CcSEcCtD
Tolterodine—Hypersensitivity—Clopidogrel—coronary artery disease	0.00017	0.00103	CcSEcCtD
Tolterodine—Anaphylactic shock—Furosemide—coronary artery disease	0.000169	0.00102	CcSEcCtD
Tolterodine—Abdominal pain—Simvastatin—coronary artery disease	0.000169	0.00102	CcSEcCtD
Tolterodine—Headache—Rosuvastatin—coronary artery disease	0.000169	0.00102	CcSEcCtD
Tolterodine—Hypersensitivity—Lovastatin—coronary artery disease	0.000168	0.00102	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Telmisartan—coronary artery disease	0.000168	0.00102	CcSEcCtD
Tolterodine—Asthenia—Fenofibrate—coronary artery disease	0.000168	0.00102	CcSEcCtD
Tolterodine—Pain—Niacin—coronary artery disease	0.000168	0.00102	CcSEcCtD
Tolterodine—Somnolence—Trandolapril—coronary artery disease	0.000167	0.00101	CcSEcCtD
Tolterodine—Fatigue—Pravastatin—coronary artery disease	0.000167	0.00101	CcSEcCtD
Tolterodine—Dry mouth—Losartan—coronary artery disease	0.000167	0.00101	CcSEcCtD
Tolterodine—Somnolence—Enalapril—coronary artery disease	0.000166	0.00101	CcSEcCtD
Tolterodine—Flushing—Lisinopril—coronary artery disease	0.000166	0.001	CcSEcCtD
Tolterodine—Feeling abnormal—Olmesartan—coronary artery disease	0.000166	0.001	CcSEcCtD
Tolterodine—Pain—Pravastatin—coronary artery disease	0.000165	0.001	CcSEcCtD
Tolterodine—Constipation—Pravastatin—coronary artery disease	0.000165	0.001	CcSEcCtD
Tolterodine—Dyspepsia—Trandolapril—coronary artery disease	0.000165	0.000999	CcSEcCtD
Tolterodine—Hypersensitivity—Ezetimibe—coronary artery disease	0.000165	0.000999	CcSEcCtD
Tolterodine—Gastrointestinal pain—Valsartan—coronary artery disease	0.000165	0.000998	CcSEcCtD
Tolterodine—Asthenia—Clopidogrel—coronary artery disease	0.000165	0.000998	CcSEcCtD
Tolterodine—Confusional state—Losartan—coronary artery disease	0.000165	0.000996	CcSEcCtD
Tolterodine—Dyspepsia—Enalapril—coronary artery disease	0.000165	0.000995	CcSEcCtD
Tolterodine—Gastrointestinal pain—Olmesartan—coronary artery disease	0.000164	0.000994	CcSEcCtD
Tolterodine—Asthenia—Lovastatin—coronary artery disease	0.000164	0.000992	CcSEcCtD
Tolterodine—Somnolence—Telmisartan—coronary artery disease	0.000164	0.000991	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000163	0.000988	CcSEcCtD
Tolterodine—Anaphylactic shock—Losartan—coronary artery disease	0.000163	0.000987	CcSEcCtD
Tolterodine—Oedema—Losartan—coronary artery disease	0.000163	0.000987	CcSEcCtD
Tolterodine—Dyspepsia—Telmisartan—coronary artery disease	0.000162	0.000982	CcSEcCtD
Tolterodine—Infection—Losartan—coronary artery disease	0.000162	0.000981	CcSEcCtD
Tolterodine—Fatigue—Trandolapril—coronary artery disease	0.000162	0.000979	CcSEcCtD
Tolterodine—Fatigue—Enalapril—coronary artery disease	0.000161	0.000975	CcSEcCtD
Tolterodine—Asthenia—Ezetimibe—coronary artery disease	0.000161	0.000973	CcSEcCtD
Tolterodine—Gastrointestinal pain—Niacin—coronary artery disease	0.000161	0.000971	CcSEcCtD
Tolterodine—Constipation—Trandolapril—coronary artery disease	0.000161	0.000971	CcSEcCtD
Tolterodine—Diarrhoea—Fenofibrate—coronary artery disease	0.00016	0.000969	CcSEcCtD
Tolterodine—Constipation—Enalapril—coronary artery disease	0.00016	0.000967	CcSEcCtD
Tolterodine—Abdominal pain—Valsartan—coronary artery disease	0.00016	0.000965	CcSEcCtD
Tolterodine—Somnolence—Captopril—coronary artery disease	0.000159	0.000964	CcSEcCtD
Tolterodine—Tachycardia—Losartan—coronary artery disease	0.000159	0.000964	CcSEcCtD
Tolterodine—Feeling abnormal—Pravastatin—coronary artery disease	0.000159	0.000963	CcSEcCtD
Tolterodine—Fatigue—Telmisartan—coronary artery disease	0.000159	0.000961	CcSEcCtD
Tolterodine—Abdominal pain—Olmesartan—coronary artery disease	0.000159	0.000961	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000159	0.000959	CcSEcCtD
Tolterodine—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000158	0.000956	CcSEcCtD
Tolterodine—Dyspepsia—Captopril—coronary artery disease	0.000158	0.000954	CcSEcCtD
Tolterodine—Pain—Telmisartan—coronary artery disease	0.000158	0.000954	CcSEcCtD
Tolterodine—Constipation—Telmisartan—coronary artery disease	0.000158	0.000954	CcSEcCtD
Tolterodine—Hypersensitivity—Simvastatin—coronary artery disease	0.000158	0.000953	CcSEcCtD
Tolterodine—Diarrhoea—Clopidogrel—coronary artery disease	0.000157	0.000952	CcSEcCtD
Tolterodine—Asthenia—Eplerenone—coronary artery disease	0.000157	0.000952	CcSEcCtD
Tolterodine—Angioedema—Ramipril—coronary artery disease	0.000157	0.000948	CcSEcCtD
Tolterodine—Diarrhoea—Lovastatin—coronary artery disease	0.000156	0.000946	CcSEcCtD
Tolterodine—Abdominal pain—Niacin—coronary artery disease	0.000155	0.000938	CcSEcCtD
Tolterodine—Dizziness—Fenofibrate—coronary artery disease	0.000155	0.000936	CcSEcCtD
Tolterodine—Somnolence—Perindopril—coronary artery disease	0.000155	0.000936	CcSEcCtD
Tolterodine—Feeling abnormal—Trandolapril—coronary artery disease	0.000155	0.000935	CcSEcCtD
Tolterodine—Fatigue—Captopril—coronary artery disease	0.000155	0.000935	CcSEcCtD
Tolterodine—Vertigo—Ramipril—coronary artery disease	0.000154	0.000932	CcSEcCtD
Tolterodine—Feeling abnormal—Enalapril—coronary artery disease	0.000154	0.000932	CcSEcCtD
Tolterodine—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000154	0.000928	CcSEcCtD
Tolterodine—Asthenia—Simvastatin—coronary artery disease	0.000153	0.000928	CcSEcCtD
Tolterodine—Diarrhoea—Ezetimibe—coronary artery disease	0.000153	0.000928	CcSEcCtD
Tolterodine—Constipation—Captopril—coronary artery disease	0.000153	0.000927	CcSEcCtD
Tolterodine—Flatulence—Lisinopril—coronary artery disease	0.000153	0.000927	CcSEcCtD
Tolterodine—Angioedema—Timolol—coronary artery disease	0.000153	0.000927	CcSEcCtD
Tolterodine—Dyspepsia—Perindopril—coronary artery disease	0.000153	0.000927	CcSEcCtD
Tolterodine—Gastrointestinal pain—Enalapril—coronary artery disease	0.000153	0.000924	CcSEcCtD
Tolterodine—Abdominal pain—Pravastatin—coronary artery disease	0.000153	0.000924	CcSEcCtD
Tolterodine—Dizziness—Clopidogrel—coronary artery disease	0.000152	0.00092	CcSEcCtD
Tolterodine—Feeling abnormal—Telmisartan—coronary artery disease	0.000152	0.000919	CcSEcCtD
Tolterodine—Palpitations—Ramipril—coronary artery disease	0.000152	0.000917	CcSEcCtD
Tolterodine—Dizziness—Lovastatin—coronary artery disease	0.000151	0.000914	CcSEcCtD
Tolterodine—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000151	0.000912	CcSEcCtD
Tolterodine—Vertigo—Timolol—coronary artery disease	0.000151	0.000911	CcSEcCtD
Tolterodine—Somnolence—Furosemide—coronary artery disease	0.00015	0.00091	CcSEcCtD
Tolterodine—Diarrhoea—Eplerenone—coronary artery disease	0.00015	0.000908	CcSEcCtD
Tolterodine—Fatigue—Perindopril—coronary artery disease	0.00015	0.000908	CcSEcCtD
Tolterodine—Brompheniramine—CYP2C19—coronary artery disease	0.00015	0.0605	CrCbGaD
Tolterodine—Constipation—Perindopril—coronary artery disease	0.000149	0.0009	CcSEcCtD
Tolterodine—Pain—Perindopril—coronary artery disease	0.000149	0.0009	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000149	0.0009	CcSEcCtD
Tolterodine—Hypersensitivity—Valsartan—coronary artery disease	0.000149	0.0009	CcSEcCtD
Tolterodine—Abdominal pain—Trandolapril—coronary artery disease	0.000148	0.000897	CcSEcCtD
Tolterodine—Dizziness—Ezetimibe—coronary artery disease	0.000148	0.000896	CcSEcCtD
Tolterodine—Palpitations—Timolol—coronary artery disease	0.000148	0.000896	CcSEcCtD
Tolterodine—Abdominal pain—Enalapril—coronary artery disease	0.000148	0.000894	CcSEcCtD
Tolterodine—Feeling abnormal—Captopril—coronary artery disease	0.000148	0.000893	CcSEcCtD
Tolterodine—Headache—Fenofibrate—coronary artery disease	0.000147	0.000887	CcSEcCtD
Tolterodine—Gastrointestinal pain—Captopril—coronary artery disease	0.000147	0.000887	CcSEcCtD
Tolterodine—Diarrhoea—Simvastatin—coronary artery disease	0.000146	0.000885	CcSEcCtD
Tolterodine—Arthralgia—Ramipril—coronary artery disease	0.000146	0.000883	CcSEcCtD
Tolterodine—Chest pain—Ramipril—coronary artery disease	0.000146	0.000883	CcSEcCtD
Tolterodine—Fatigue—Furosemide—coronary artery disease	0.000146	0.000882	CcSEcCtD
Tolterodine—Abdominal pain—Telmisartan—coronary artery disease	0.000146	0.000881	CcSEcCtD
Tolterodine—Anxiety—Ramipril—coronary artery disease	0.000146	0.00088	CcSEcCtD
Tolterodine—Somnolence—Losartan—coronary artery disease	0.000145	0.000878	CcSEcCtD
Tolterodine—Dizziness—Eplerenone—coronary artery disease	0.000145	0.000877	CcSEcCtD
Tolterodine—Asthenia—Valsartan—coronary artery disease	0.000145	0.000876	CcSEcCtD
Tolterodine—Pain—Furosemide—coronary artery disease	0.000145	0.000875	CcSEcCtD
Tolterodine—Constipation—Furosemide—coronary artery disease	0.000145	0.000875	CcSEcCtD
Tolterodine—Hypersensitivity—Niacin—coronary artery disease	0.000145	0.000875	CcSEcCtD
Tolterodine—Asthenia—Olmesartan—coronary artery disease	0.000144	0.000872	CcSEcCtD
Tolterodine—Headache—Clopidogrel—coronary artery disease	0.000144	0.000872	CcSEcCtD
Tolterodine—Dyspepsia—Losartan—coronary artery disease	0.000144	0.000869	CcSEcCtD
Tolterodine—Feeling abnormal—Perindopril—coronary artery disease	0.000143	0.000868	CcSEcCtD
Tolterodine—Headache—Lovastatin—coronary artery disease	0.000143	0.000866	CcSEcCtD
Tolterodine—Dry mouth—Ramipril—coronary artery disease	0.000143	0.000864	CcSEcCtD
Tolterodine—Arthralgia—Timolol—coronary artery disease	0.000143	0.000863	CcSEcCtD
Tolterodine—Chest pain—Timolol—coronary artery disease	0.000143	0.000863	CcSEcCtD
Tolterodine—Hypersensitivity—Pravastatin—coronary artery disease	0.000142	0.000861	CcSEcCtD
Tolterodine—Gastrointestinal pain—Perindopril—coronary artery disease	0.000142	0.000861	CcSEcCtD
Tolterodine—Anxiety—Timolol—coronary artery disease	0.000142	0.00086	CcSEcCtD
Tolterodine—Angioedema—Lisinopril—coronary artery disease	0.000142	0.00086	CcSEcCtD
Tolterodine—Abdominal pain—Captopril—coronary artery disease	0.000142	0.000857	CcSEcCtD
Tolterodine—Dizziness—Simvastatin—coronary artery disease	0.000141	0.000855	CcSEcCtD
Tolterodine—Confusional state—Ramipril—coronary artery disease	0.000141	0.000854	CcSEcCtD
Tolterodine—Asthenia—Niacin—coronary artery disease	0.000141	0.000852	CcSEcCtD
Tolterodine—Fatigue—Losartan—coronary artery disease	0.000141	0.000851	CcSEcCtD
Tolterodine—Headache—Ezetimibe—coronary artery disease	0.00014	0.000849	CcSEcCtD
Tolterodine—Anaphylactic shock—Ramipril—coronary artery disease	0.00014	0.000847	CcSEcCtD
Tolterodine—Oedema—Ramipril—coronary artery disease	0.00014	0.000847	CcSEcCtD
Tolterodine—Vertigo—Lisinopril—coronary artery disease	0.00014	0.000845	CcSEcCtD
Tolterodine—Dry mouth—Timolol—coronary artery disease	0.00014	0.000844	CcSEcCtD
Tolterodine—Pain—Losartan—coronary artery disease	0.00014	0.000844	CcSEcCtD
Tolterodine—Constipation—Losartan—coronary artery disease	0.00014	0.000844	CcSEcCtD
Tolterodine—Feeling abnormal—Furosemide—coronary artery disease	0.000139	0.000843	CcSEcCtD
Tolterodine—Asthenia—Pravastatin—coronary artery disease	0.000139	0.000839	CcSEcCtD
Tolterodine—Gastrointestinal pain—Furosemide—coronary artery disease	0.000138	0.000837	CcSEcCtD
Tolterodine—Hypersensitivity—Trandolapril—coronary artery disease	0.000138	0.000836	CcSEcCtD
Tolterodine—Diarrhoea—Valsartan—coronary artery disease	0.000138	0.000835	CcSEcCtD
Tolterodine—Confusional state—Timolol—coronary artery disease	0.000138	0.000835	CcSEcCtD
Tolterodine—Hypersensitivity—Enalapril—coronary artery disease	0.000138	0.000833	CcSEcCtD
Tolterodine—Abdominal pain—Perindopril—coronary artery disease	0.000138	0.000832	CcSEcCtD
Tolterodine—Palpitations—Lisinopril—coronary artery disease	0.000138	0.000831	CcSEcCtD
Tolterodine—Diarrhoea—Olmesartan—coronary artery disease	0.000138	0.000831	CcSEcCtD
Tolterodine—Headache—Eplerenone—coronary artery disease	0.000137	0.000831	CcSEcCtD
Tolterodine—Oedema—Timolol—coronary artery disease	0.000137	0.000828	CcSEcCtD
Tolterodine—Anaphylactic shock—Timolol—coronary artery disease	0.000137	0.000828	CcSEcCtD
Tolterodine—Tachycardia—Ramipril—coronary artery disease	0.000137	0.000826	CcSEcCtD
Tolterodine—Infection—Timolol—coronary artery disease	0.000136	0.000822	CcSEcCtD
Tolterodine—Hypersensitivity—Telmisartan—coronary artery disease	0.000136	0.000822	CcSEcCtD
Tolterodine—Asthenia—Trandolapril—coronary artery disease	0.000135	0.000814	CcSEcCtD
Tolterodine—Feeling abnormal—Losartan—coronary artery disease	0.000135	0.000814	CcSEcCtD
Tolterodine—Diarrhoea—Niacin—coronary artery disease	0.000134	0.000812	CcSEcCtD
Tolterodine—Asthenia—Enalapril—coronary artery disease	0.000134	0.000811	CcSEcCtD
Tolterodine—Headache—Simvastatin—coronary artery disease	0.000134	0.00081	CcSEcCtD
Tolterodine—Abdominal pain—Furosemide—coronary artery disease	0.000134	0.000809	CcSEcCtD
Tolterodine—Gastrointestinal pain—Losartan—coronary artery disease	0.000134	0.000807	CcSEcCtD
Tolterodine—Dizziness—Valsartan—coronary artery disease	0.000134	0.000807	CcSEcCtD
Tolterodine—Dizziness—Olmesartan—coronary artery disease	0.000133	0.000803	CcSEcCtD
Tolterodine—Arthralgia—Lisinopril—coronary artery disease	0.000132	0.000801	CcSEcCtD
Tolterodine—Chest pain—Lisinopril—coronary artery disease	0.000132	0.000801	CcSEcCtD
Tolterodine—Asthenia—Telmisartan—coronary artery disease	0.000132	0.0008	CcSEcCtD
Tolterodine—Diarrhoea—Pravastatin—coronary artery disease	0.000132	0.0008	CcSEcCtD
Tolterodine—Anxiety—Lisinopril—coronary artery disease	0.000132	0.000798	CcSEcCtD
Tolterodine—Dizziness—Niacin—coronary artery disease	0.00013	0.000785	CcSEcCtD
Tolterodine—Dry mouth—Lisinopril—coronary artery disease	0.00013	0.000783	CcSEcCtD
Tolterodine—Abdominal pain—Losartan—coronary artery disease	0.000129	0.000781	CcSEcCtD
Tolterodine—Asthenia—Captopril—coronary artery disease	0.000129	0.000778	CcSEcCtD
Tolterodine—Diarrhoea—Trandolapril—coronary artery disease	0.000128	0.000777	CcSEcCtD
Tolterodine—Confusional state—Lisinopril—coronary artery disease	0.000128	0.000774	CcSEcCtD
Tolterodine—Diarrhoea—Enalapril—coronary artery disease	0.000128	0.000773	CcSEcCtD
Tolterodine—Dizziness—Pravastatin—coronary artery disease	0.000128	0.000773	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000128	0.000771	CcSEcCtD
Tolterodine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000127	0.000768	CcSEcCtD
Tolterodine—Oedema—Lisinopril—coronary artery disease	0.000127	0.000768	CcSEcCtD
Tolterodine—Headache—Valsartan—coronary artery disease	0.000127	0.000765	CcSEcCtD
Tolterodine—Diarrhoea—Telmisartan—coronary artery disease	0.000126	0.000763	CcSEcCtD
Tolterodine—Infection—Lisinopril—coronary artery disease	0.000126	0.000763	CcSEcCtD
Tolterodine—Headache—Olmesartan—coronary artery disease	0.000126	0.000761	CcSEcCtD
Tolterodine—Asthenia—Perindopril—coronary artery disease	0.000125	0.000755	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000125	0.000754	CcSEcCtD
Tolterodine—Hypersensitivity—Furosemide—coronary artery disease	0.000125	0.000754	CcSEcCtD
Tolterodine—Somnolence—Ramipril—coronary artery disease	0.000124	0.000753	CcSEcCtD
Tolterodine—Dizziness—Trandolapril—coronary artery disease	0.000124	0.000751	CcSEcCtD
Tolterodine—Tachycardia—Lisinopril—coronary artery disease	0.000124	0.000749	CcSEcCtD
Tolterodine—Dizziness—Enalapril—coronary artery disease	0.000124	0.000748	CcSEcCtD
Tolterodine—Atomoxetine—CYP2C19—coronary artery disease	0.000124	0.0499	CrCbGaD
Tolterodine—Dyspepsia—Ramipril—coronary artery disease	0.000123	0.000745	CcSEcCtD
Tolterodine—Headache—Niacin—coronary artery disease	0.000123	0.000744	CcSEcCtD
Tolterodine—Diarrhoea—Captopril—coronary artery disease	0.000123	0.000742	CcSEcCtD
Tolterodine—Dizziness—Telmisartan—coronary artery disease	0.000122	0.000737	CcSEcCtD
Tolterodine—Somnolence—Timolol—coronary artery disease	0.000122	0.000736	CcSEcCtD
Tolterodine—Asthenia—Furosemide—coronary artery disease	0.000121	0.000734	CcSEcCtD
Tolterodine—Headache—Pravastatin—coronary artery disease	0.000121	0.000732	CcSEcCtD
Tolterodine—Fatigue—Ramipril—coronary artery disease	0.000121	0.00073	CcSEcCtD
Tolterodine—Dyspepsia—Timolol—coronary artery disease	0.000121	0.000729	CcSEcCtD
Tolterodine—Hypersensitivity—Losartan—coronary artery disease	0.00012	0.000727	CcSEcCtD
Tolterodine—Constipation—Ramipril—coronary artery disease	0.00012	0.000724	CcSEcCtD
Tolterodine—Diarrhoea—Perindopril—coronary artery disease	0.000119	0.00072	CcSEcCtD
Tolterodine—Dizziness—Captopril—coronary artery disease	0.000119	0.000717	CcSEcCtD
Tolterodine—Fatigue—Timolol—coronary artery disease	0.000118	0.000714	CcSEcCtD
Tolterodine—Headache—Trandolapril—coronary artery disease	0.000118	0.000711	CcSEcCtD
Tolterodine—Asthenia—Losartan—coronary artery disease	0.000117	0.000708	CcSEcCtD
Tolterodine—Headache—Enalapril—coronary artery disease	0.000117	0.000708	CcSEcCtD
Tolterodine—Pain—Timolol—coronary artery disease	0.000117	0.000708	CcSEcCtD
Tolterodine—Diarrhoea—Furosemide—coronary artery disease	0.000116	0.0007	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000116	0.0007	CcSEcCtD
Tolterodine—Headache—Telmisartan—coronary artery disease	0.000116	0.000699	CcSEcCtD
Tolterodine—Feeling abnormal—Ramipril—coronary artery disease	0.000115	0.000698	CcSEcCtD
Tolterodine—Dizziness—Perindopril—coronary artery disease	0.000115	0.000696	CcSEcCtD
Tolterodine—Gastrointestinal pain—Ramipril—coronary artery disease	0.000115	0.000692	CcSEcCtD
Tolterodine—Somnolence—Lisinopril—coronary artery disease	0.000113	0.000683	CcSEcCtD
Tolterodine—Feeling abnormal—Timolol—coronary artery disease	0.000113	0.000682	CcSEcCtD
Tolterodine—Headache—Captopril—coronary artery disease	0.000112	0.000679	CcSEcCtD
Tolterodine—Gastrointestinal pain—Timolol—coronary artery disease	0.000112	0.000677	CcSEcCtD
Tolterodine—Dizziness—Furosemide—coronary artery disease	0.000112	0.000677	CcSEcCtD
Tolterodine—Dyspepsia—Lisinopril—coronary artery disease	0.000112	0.000676	CcSEcCtD
Tolterodine—Diarrhoea—Losartan—coronary artery disease	0.000112	0.000676	CcSEcCtD
Tolterodine—Abdominal pain—Ramipril—coronary artery disease	0.000111	0.000669	CcSEcCtD
Tolterodine—Phenprocoumon—ALB—coronary artery disease	0.00011	0.0443	CrCbGaD
Tolterodine—Fatigue—Lisinopril—coronary artery disease	0.000109	0.000662	CcSEcCtD
Tolterodine—Headache—Perindopril—coronary artery disease	0.000109	0.000659	CcSEcCtD
Tolterodine—Constipation—Lisinopril—coronary artery disease	0.000109	0.000657	CcSEcCtD
Tolterodine—Pain—Lisinopril—coronary artery disease	0.000109	0.000657	CcSEcCtD
Tolterodine—Abdominal pain—Timolol—coronary artery disease	0.000108	0.000654	CcSEcCtD
Tolterodine—Dizziness—Losartan—coronary artery disease	0.000108	0.000653	CcSEcCtD
Tolterodine—Headache—Furosemide—coronary artery disease	0.000106	0.000641	CcSEcCtD
Tolterodine—Feeling abnormal—Lisinopril—coronary artery disease	0.000105	0.000633	CcSEcCtD
Tolterodine—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000104	0.000628	CcSEcCtD
Tolterodine—Hypersensitivity—Ramipril—coronary artery disease	0.000103	0.000624	CcSEcCtD
Tolterodine—Headache—Losartan—coronary artery disease	0.000102	0.000619	CcSEcCtD
Tolterodine—Hypersensitivity—Timolol—coronary artery disease	0.000101	0.00061	CcSEcCtD
Tolterodine—Asthenia—Ramipril—coronary artery disease	0.0001	0.000607	CcSEcCtD
Tolterodine—Abdominal pain—Lisinopril—coronary artery disease	0.0001	0.000607	CcSEcCtD
Tolterodine—Atomoxetine—HTR2A—coronary artery disease	0.0001	0.0405	CrCbGaD
Tolterodine—Asthenia—Timolol—coronary artery disease	9.82e-05	0.000594	CcSEcCtD
Tolterodine—Diarrhoea—Ramipril—coronary artery disease	9.58e-05	0.000579	CcSEcCtD
Tolterodine—Diarrhoea—Timolol—coronary artery disease	9.37e-05	0.000566	CcSEcCtD
Tolterodine—Hypersensitivity—Lisinopril—coronary artery disease	9.36e-05	0.000566	CcSEcCtD
Tolterodine—Dizziness—Ramipril—coronary artery disease	9.26e-05	0.00056	CcSEcCtD
Tolterodine—Asthenia—Lisinopril—coronary artery disease	9.11e-05	0.000551	CcSEcCtD
Tolterodine—Dizziness—Timolol—coronary artery disease	9.05e-05	0.000547	CcSEcCtD
Tolterodine—Headache—Ramipril—coronary artery disease	8.77e-05	0.00053	CcSEcCtD
Tolterodine—Diarrhoea—Lisinopril—coronary artery disease	8.69e-05	0.000525	CcSEcCtD
Tolterodine—Headache—Timolol—coronary artery disease	8.58e-05	0.000519	CcSEcCtD
Tolterodine—Dizziness—Lisinopril—coronary artery disease	8.4e-05	0.000508	CcSEcCtD
Tolterodine—Headache—Lisinopril—coronary artery disease	7.96e-05	0.000481	CcSEcCtD
Tolterodine—CHRM2—Signaling Pathways—AGT—coronary artery disease	3.59e-06	3.66e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—LEP—coronary artery disease	3.56e-06	3.63e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APOE—coronary artery disease	3.56e-06	3.63e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—VCAN—coronary artery disease	3.56e-06	3.62e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CAT—coronary artery disease	3.55e-06	3.62e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—LEP—coronary artery disease	3.55e-06	3.62e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APOE—coronary artery disease	3.55e-06	3.62e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.53e-06	3.59e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APOA1—coronary artery disease	3.52e-06	3.59e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APOE—coronary artery disease	3.52e-06	3.58e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—LEP—coronary artery disease	3.52e-06	3.58e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CXCL8—coronary artery disease	3.51e-06	3.58e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APOA1—coronary artery disease	3.51e-06	3.57e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—KDR—coronary artery disease	3.49e-06	3.55e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—KDR—coronary artery disease	3.48e-06	3.54e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APOA1—coronary artery disease	3.48e-06	3.54e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	3.47e-06	3.53e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	3.46e-06	3.52e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOB—coronary artery disease	3.45e-06	3.51e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—KDR—coronary artery disease	3.45e-06	3.51e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—DCN—coronary artery disease	3.42e-06	3.49e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	3.42e-06	3.49e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ESR1—coronary artery disease	3.4e-06	3.46e-05	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—AKT1—coronary artery disease	3.39e-06	3.45e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ESR1—coronary artery disease	3.39e-06	3.45e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CXCL8—coronary artery disease	3.36e-06	3.42e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CASP3—coronary artery disease	3.36e-06	3.42e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—F2—coronary artery disease	3.36e-06	3.42e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FN1—coronary artery disease	3.36e-06	3.42e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.36e-06	3.42e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	3.36e-06	3.42e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTM1—coronary artery disease	3.36e-06	3.42e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—F2—coronary artery disease	3.35e-06	3.41e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FN1—coronary artery disease	3.35e-06	3.41e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	3.35e-06	3.41e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6—coronary artery disease	3.34e-06	3.4e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	3.34e-06	3.4e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.33e-06	3.39e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTP1—coronary artery disease	3.33e-06	3.39e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.33e-06	3.39e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ALB—coronary artery disease	3.33e-06	3.39e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	3.32e-06	3.38e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FN1—coronary artery disease	3.32e-06	3.38e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—F2—coronary artery disease	3.32e-06	3.38e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.31e-06	3.37e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	3.31e-06	3.37e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	3.3e-06	3.36e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	3.3e-06	3.36e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—LPL—coronary artery disease	3.29e-06	3.35e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—HMOX1—coronary artery disease	3.28e-06	3.34e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	3.28e-06	3.34e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCND1—coronary artery disease	3.27e-06	3.33e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CAT—coronary artery disease	3.27e-06	3.33e-05	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—AKT1—coronary artery disease	3.25e-06	3.31e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—LIPC—coronary artery disease	3.25e-06	3.31e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HBA1—coronary artery disease	3.25e-06	3.31e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.25e-06	3.31e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.25e-06	3.31e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CAT—coronary artery disease	3.24e-06	3.3e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOC3—coronary artery disease	3.23e-06	3.28e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CASP3—coronary artery disease	3.22e-06	3.28e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—KIT—coronary artery disease	3.22e-06	3.27e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GPX1—coronary artery disease	3.21e-06	3.27e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—LDLR—coronary artery disease	3.21e-06	3.26e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—KIT—coronary artery disease	3.21e-06	3.26e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6—coronary artery disease	3.2e-06	3.26e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—NOS3—coronary artery disease	3.18e-06	3.24e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MMP9—coronary artery disease	3.18e-06	3.23e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—KIT—coronary artery disease	3.17e-06	3.23e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOB—coronary artery disease	3.17e-06	3.23e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.17e-06	3.23e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.17e-06	3.23e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOB—coronary artery disease	3.15e-06	3.2e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCND1—coronary artery disease	3.13e-06	3.19e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GCLC—coronary artery disease	3.13e-06	3.19e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CETP—coronary artery disease	3.13e-06	3.19e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CD36—coronary artery disease	3.13e-06	3.19e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SDC1—coronary artery disease	3.1e-06	3.15e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPP2CA—coronary artery disease	3.09e-06	3.15e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTM1—coronary artery disease	3.09e-06	3.14e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	3.09e-06	3.14e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—AKT1—coronary artery disease	3.08e-06	3.14e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	3.08e-06	3.13e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—POMC—coronary artery disease	3.06e-06	3.12e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CREB1—coronary artery disease	3.06e-06	3.12e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTM1—coronary artery disease	3.06e-06	3.12e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—POMC—coronary artery disease	3.05e-06	3.11e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CREB1—coronary artery disease	3.05e-06	3.11e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	3.05e-06	3.1e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MMP9—coronary artery disease	3.04e-06	3.1e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—LPL—coronary artery disease	3.03e-06	3.09e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—POMC—coronary artery disease	3.02e-06	3.08e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	3.02e-06	3.08e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—LPL—coronary artery disease	3e-06	3.06e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL2—coronary artery disease	3e-06	3.05e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6R—coronary artery disease	2.99e-06	3.04e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL2—coronary artery disease	2.99e-06	3.04e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6R—coronary artery disease	2.98e-06	3.03e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MTHFR—coronary artery disease	2.97e-06	3.02e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	2.96e-06	3.01e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GPX1—coronary artery disease	2.96e-06	3.01e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—AKT1—coronary artery disease	2.95e-06	3e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	2.95e-06	3e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF1—coronary artery disease	2.94e-06	3e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF1—coronary artery disease	2.94e-06	2.99e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GPX1—coronary artery disease	2.93e-06	2.98e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	2.93e-06	2.98e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.93e-06	2.98e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.93e-06	2.98e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	2.92e-06	2.97e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTGS2—coronary artery disease	2.91e-06	2.96e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	2.91e-06	2.96e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	2.89e-06	2.95e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CD36—coronary artery disease	2.88e-06	2.93e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CTGF—coronary artery disease	2.86e-06	2.91e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CD36—coronary artery disease	2.85e-06	2.91e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—VEGFA—coronary artery disease	2.85e-06	2.9e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.84e-06	2.89e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.83e-06	2.88e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GOT2—coronary artery disease	2.83e-06	2.88e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.82e-06	2.87e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AGT—coronary artery disease	2.82e-06	2.87e-05	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.8e-06	2.85e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	2.8e-06	2.85e-05	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	2.79e-06	2.84e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	2.79e-06	2.84e-05	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	2.76e-06	2.81e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOE—coronary artery disease	2.76e-06	2.81e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	2.76e-06	2.81e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—VEGFA—coronary artery disease	2.73e-06	2.78e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOA1—coronary artery disease	2.73e-06	2.78e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.73e-06	2.78e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FGF2—coronary artery disease	2.71e-06	2.76e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.7e-06	2.75e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FGF2—coronary artery disease	2.7e-06	2.75e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	2.67e-06	2.72e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NOS3—coronary artery disease	2.67e-06	2.72e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NOS3—coronary artery disease	2.66e-06	2.71e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	2.64e-06	2.68e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TGFB1—coronary artery disease	2.62e-06	2.67e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.61e-06	2.66e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.6e-06	2.65e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	2.59e-06	2.64e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AGT—coronary artery disease	2.59e-06	2.64e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—JAK2—coronary artery disease	2.59e-06	2.63e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AGT—coronary artery disease	2.57e-06	2.62e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MAPK1—coronary artery disease	2.57e-06	2.61e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	2.56e-06	2.61e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	2.54e-06	2.59e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOE—coronary artery disease	2.54e-06	2.59e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	2.53e-06	2.58e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.52e-06	2.57e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOE—coronary artery disease	2.52e-06	2.56e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOA1—coronary artery disease	2.51e-06	2.56e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	2.51e-06	2.56e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	2.51e-06	2.55e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOA1—coronary artery disease	2.49e-06	2.53e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	2.46e-06	2.5e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GGT1—coronary artery disease	2.45e-06	2.49e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GOT1—coronary artery disease	2.45e-06	2.49e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPARG—coronary artery disease	2.41e-06	2.45e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.38e-06	2.43e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—POMC—coronary artery disease	2.37e-06	2.42e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	2.37e-06	2.41e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	2.36e-06	2.4e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	2.34e-06	2.38e-05	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	2.29e-06	2.33e-05	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	2.28e-06	2.32e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	2.27e-06	2.31e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CASP3—coronary artery disease	2.26e-06	2.3e-05	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	2.26e-06	2.3e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	2.25e-06	2.29e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6—coronary artery disease	2.24e-06	2.29e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	2.24e-06	2.28e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	2.23e-06	2.27e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	2.22e-06	2.26e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARG—coronary artery disease	2.21e-06	2.25e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	2.21e-06	2.25e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCND1—coronary artery disease	2.2e-06	2.24e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.2e-06	2.24e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARG—coronary artery disease	2.19e-06	2.23e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—POMC—coronary artery disease	2.18e-06	2.22e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	2.18e-06	2.22e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.18e-06	2.22e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.17e-06	2.21e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—POMC—coronary artery disease	2.16e-06	2.2e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ALB—coronary artery disease	2.16e-06	2.2e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	2.14e-06	2.18e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CAT—coronary artery disease	2.14e-06	2.18e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MMP9—coronary artery disease	2.13e-06	2.17e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	2.13e-06	2.17e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	2.11e-06	2.15e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	2.08e-06	2.11e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOB—coronary artery disease	2.07e-06	2.11e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	2.07e-06	2.11e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NOS3—coronary artery disease	2.07e-06	2.11e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	2.05e-06	2.09e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.02e-06	2.05e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ALB—coronary artery disease	1.99e-06	2.03e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—LPL—coronary artery disease	1.98e-06	2.02e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6—coronary artery disease	1.97e-06	2.01e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ALB—coronary artery disease	1.97e-06	2.01e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GPX1—coronary artery disease	1.93e-06	1.97e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	1.92e-06	1.96e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	1.92e-06	1.95e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NOS3—coronary artery disease	1.9e-06	1.94e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	1.9e-06	1.93e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.89e-06	1.93e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6—coronary artery disease	1.89e-06	1.92e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NOS3—coronary artery disease	1.89e-06	1.92e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CD36—coronary artery disease	1.88e-06	1.92e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.86e-06	1.89e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—AKT1—coronary artery disease	1.82e-06	1.85e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CA—coronary artery disease	1.79e-06	1.82e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.78e-06	1.82e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	1.77e-06	1.8e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	1.76e-06	1.79e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—AKT1—coronary artery disease	1.74e-06	1.77e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	1.74e-06	1.77e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.74e-06	1.77e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	1.73e-06	1.76e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	1.73e-06	1.76e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.73e-06	1.76e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	1.71e-06	1.74e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AGT—coronary artery disease	1.69e-06	1.73e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOE—coronary artery disease	1.66e-06	1.69e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOA1—coronary artery disease	1.64e-06	1.67e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.5e-06	1.53e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	1.5e-06	1.52e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	1.48e-06	1.51e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—AKT1—coronary artery disease	1.46e-06	1.49e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.45e-06	1.47e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—POMC—coronary artery disease	1.43e-06	1.45e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6—coronary artery disease	1.33e-06	1.35e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6—coronary artery disease	1.33e-06	1.35e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6—coronary artery disease	1.31e-06	1.34e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ALB—coronary artery disease	1.3e-06	1.32e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.24e-06	1.27e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	1.23e-06	1.25e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AKT1—coronary artery disease	1.22e-06	1.25e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	1.21e-06	1.23e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.16e-06	1.19e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.14e-06	1.16e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.07e-06	1.09e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.06e-06	1.08e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AKT1—coronary artery disease	9.51e-07	9.68e-06	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AKT1—coronary artery disease	8.75e-07	8.91e-06	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AKT1—coronary artery disease	8.67e-07	8.83e-06	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7e-07	7.13e-06	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AKT1—coronary artery disease	5.72e-07	5.82e-06	CbGpPWpGaD
